Canopy Growth (TSX:WEED) Is Poised to Soar Like Amazon

The long-term outlook for Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is positive despite short-term issues.

| More on:

Cannabis stocks have been some of the hottest investments to own in recent years, many including Canopy Growth (TSX:WEED)(NYSE:CGC) have generated incredible returns. Since going public in April 2014, Canopy has gained a whopping 1,620%, and despite growing concerns over the viability of the legal cannabis industry, there are signs of further growth to come.

As the rough ride endured by online retail behemoth Amazon.com demonstrates, there will always be hiccups for any company operating in an emerging industry. Even after the tech bust, global financial crisis, European sovereign debt crisis, and oil crash, it has returned over 116,000%, after allowing for stock splits, since its 1997 IPO.

This highlights that when investing in rapidly emerging transformative industries, it is important to invest in companies that have established a leading long-term position.

Leading global cannabis company

It is here that Canopy’s appeal comes to the fore. The cultivator’s shock fiscal 2019 result was particularly worrying for investors, because its loss ballooned out to a massive $670 million, or 12 times greater than the $54 million loss reported a year earlier. The fear among major shareholders, including liquor giant Constellation Brands, is that Canopy will be unprofitable, despite it being the world’s largest publicly listed cultivator and the significant growth forecast for global marijuana sales.

Those fears are being fanned by disparate analyst forecasts regarding the size of the global legal cannabis market, which has been estimated to be worth as much as US$155 billion or as little as US$40 billion. That degree of uncertainty doesn’t sit well with investors.

Nonetheless, what is undeniable is that the legal cannabis industry is here to stay and will continue to expand at a decent clip.

Canopy, as the world’s largest publicly listed cannabis cultivator, has developed a global reach through a series of acquisitions and distribution agreements. It has established cultivation operations in Canada, Colombia, Germany, and South Africa as well as an important springboard into the U.S. for when the federal government legalizes the plants use. Canopy has done this by establishing an agreement to acquire U.S. multi-state cannabis company Acreage Holdings when the general cultivation, distribution, and possession of marijuana is federally permitted.

Another worrying issue is Canopy’s high production costs and lack of profitability. For fiscal 2019, it reported total cost of sales of $5.65 per gram of cannabis sold, whereas production costs were $7.21 per gram before adjustments. These are significantly higher than many other cultivators, including Aphria, which reported fiscal third-quarter 2019 all-in cost of sales of $3.76 per gram. This highlights that Canopy needs to work fast to reduce costs and boost profitability.

Despite the doom and gloom, Canopy is likely to be one of the very few industry survivors to perform strongly after the cannabis bubble bursts. This is because of its first-mover advantage and growing economic moat in an industry with few significant barriers to entry. Canopy has built state-of-the-art cultivating and processing facilities, established a global distribution network, and registered 90 patents with another 240 applications underway.

Canopy also doubled down on Colombia, which is a low-cost jurisdiction where analysts estimate that the production costs will be around $0.50 per gram of dried flower. In June 2019, Canopy disclosed that it had roughly tripled its licensed cultivating area to 13.6 million square feet and had entered an agreement with Colombian pharmaceutical company Procaps to develop cannabis oil-based products. This coupled with other initiatives will lead to lower costs.

After finishing fiscal 2019 with $2.5 billion in cash, Canopy has more than enough capital to continue developing its operations.

Foolish takeaway

For these reasons, Canopy will emerge as the leading legal cannabis producer, despite the current issues that have sparked concern among investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Matt Smith has no position in any of the stocks mentioned. David Gardner owns shares of Amazon. The Motley Fool owns shares of Amazon.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »